Victoza (liraglutide), a popular drug used in Delaware and around the world to treat Type 2 diabetes, has been linked to serious and life-threatening side effects including acute pancreatitis and pancreatic cancer. Medical safety experts are concerned by study findings which show pancreatic problems such as pancreatic cancer and pancreatitis are more common with Victoza than comparable drugs. Given this fact, experts now suggest Victoza risks may outweigh potential benefits of the drug. Victoza puts Delaware patients at risk for pancreatic cancer, and many allege the company knew of the risk and failed to warn consumers.
Victoza is the best-selling product of Novo Nordisk, a leading Danish pharmaceutical company. Victoza was approved in January of 2010, against the recommendation of three FDA safety experts. Victoza dominates the market in its drug class, occupying 72% of the market share and yielded sales of approximately $2 billion in 2014.
Most patients and doctors in Delaware and around the U.S. were unaware of the danger of pancreatic cancer from Victoza. Novo Nordisk, the Danish pharmaceutical company responsible for Victoza, settled a U.S. Department of Justice lawsuit in September of 2017 for $58.65 million over illegal marketing tactics. Eight lawsuits alleged the company violated federal regulations by disguising sales representatives as medical educators who downplayed the importance of FDA Victoza cancer warnings to physicians. Without knowledge of Victoza pancreas risks, patients were unable to make an informed choice about diabetes treatment.
Delaware persons and the family members of Delaware persons who have developed pancreas problems such as pancreatitis or pancreatic cancer from Victoza may be eligible to collect real compensation by filing a Victoza lawsuit for Delaware residents against Novo Nordisk. Research linking pancreatic cancer to Victoza is available, yet Delaware patients and doctors have not been clearly warned. Unfortunately, the threat of Victoza lawsuits from Delaware residents suffering from pancreatic cancer may be the only means to pressure Novo Nordisk to take action to safeguard patient safety.
Contact our firm today for a free, no-obligation Victoza pancreatic cancer lawsuit case review for residents of Delaware. Should you choose to retain our attorneys handling Victoza claims from Delaware, there is never any fee unless we win compensation on your behalf.
If you or a member of your family in Delaware have suffered from side effects of Victoza such as acute pancreatitis or pancreatic cancer, you may have grounds to file a Victoza lawsuit against the Danish drugmaker Novo Nordisk. Victoza cancer lawsuits allow Delaware persons and families harmed by Victoza pancreas problems to seek compensation for the medical expenses, pain and suffering that have resulted from this dangerous drug.
Plaintiffs in Delaware filing Victoza pancreatic cancer lawsuits are seeking damages, saying Novo Nordisk knew of, or should have known of, the risk for pancreatic cancer and acute pancreatitis from Victoza. The company failed to sufficiently warn doctors or patients in Delaware. In fact, the term “pancreatic cancer” does not appear on the drug's warning label. Studies show that patients taking Victoza for Type 2 diabetes are 3.7 times more likely to develop acute pancreatitis than those taking a different drug to moderate blood sugar levels, and a peer-reviewed medical study identified pancreatic cancer cell growth has been identified in Victoza users.
Victoza occupies the majority market share for incretin mimetics, a particular type of Type 2 diabetes drug that is used prominently across the globe. Despite concerns about the safety of Victoza from the start - the drug received FDA approval against the recommendations of three FDA safety experts - the drug has become Novo Nordisk's best selling product. Victoza yielded sales of approximately $2 billion in 2014. Novo Nordisk paid more than $58 million in September of 2017 to resolve a U.S. Department of Justice suit for illegal marketing methods and the payment of physician kickbacks.
If you or a member of your family developed pancreatic cancer or acute pancreatitis from taking Victoza in Delaware , you may qualify to file a Victoza lawsuit to recover compensation for damages you have suffered as a result of this dangerous drug. Filing a lawsuit is the only way to secure compensation for medical bills, lost time at work, pain, suffering and loss that have resulted from Victoza pancreatic cancer or other pancreas problems. Our attorneys accept Victoza lawsuits from around the United States, and offer no-cost, no-obligation Victoza lawsuit case review for Delaware persons who match this description. To discuss your situation in detail with an attorney and to learn about Victoza lawsuit time limits in Delaware, please complete our online contact form. One of our attorneys handling Victoza pancreatitis claims from Delaware will contact you promptly.
Many persons in Delaware who have been harmed by Victoza pancreas problems wonder if filing a Victoza lawsuit will result in meaningful compensation for their family. Victoza pancreatic cancer lawsuits will not be class action lawsuits in which those who file a claim can expect only a small, symbolic settlement. On the contrary, lawyers handling Victoza lawsuits for Delaware residents believe persons and family members of persons who have developed pancreatic cancer or acute pancreatitis as a result of using Victoza may be entitled to significant compensation. While Delaware Victoza pancreatic cancer lawsuits are being consolidated as Multi-District Litigation (MDL) with other claims originating nationwide, each claim will be handled on its own merit and compensation will be determined based on the degree of suffering of each plaintiff.
We will represent all Delaware residents involved in a Victoza pancreatic cancer lawsuit on a contingency basis, meaning our lawyers never charge legal fees unless we win compensation in your case. For a free no-obligation consultation please fill out our short online contact form and one of our Victoza attorneys handling Delaware cases will contact you to answer any of your questions.
Read below to find answers to common Victoza lawsuit questions that apply to most Victoza claims for acute pancreatitis or pancreatic cancer from Delaware. To speak about your circumstances in detail, contact our firm. Our team of attorneys handling Victoza pancreatic cancer lawsuit claims of those from Delaware provides free, no obligation Delaware Victoza pancreatic cancer case review. Simply contact our firm and one of our experienced lawyers handling national Victoza lawsuit claims will contact you to answer your questions, completely free of charge.
The lawyers at The Onder Law Firm handling Delaware Victoza pancreatic cancer cases have a distinguished track record of success in achieving justice on behalf of American families harmed by multinational pharmaceutical conglomerates. Our expert Victoza lawyers have seen the aftereffects of numerous drug recalls, and have won significant compensation for our clients. Cognizant of the very serious nature of Delaware Victoza pancreatic cancer claims, this national drug litigation law firm is offering its significant resources to provide clients with the best Victoza attorney representation possible, regardless of where you reside.
Our Victoza lawyers believe persons and family members of persons who suffered from acute pancreatitis or pancreatic cancer after taking Victoza may be eligible for real compensation for the pain, suffering, medical expenses, lost income and other damages suffered by filing a claim against Novo Nordisk. Victoza puts American patients at risk for pancreatic cancer, and many allege the company knew of the risk and failed to warn consumers. Novo Nordisk recently settled a large Department of Justice lawsuit, over allegations the company engaged in illegal marketing practices to promote the drug and downplay the risk of pancreatic cancer.
Victoza pancreatic cancer lawyers believe that filing lawsuits nationwide is the only effective method to seek compensation for the harm resulting from this dangerous drug. Furthermore, It is an unfortunate fact that the threat of litigation may be the only way to motivate Novo Nordisk to prioritize consumer safety over profits.
Our Victoza attorneys will provide a free case review to persons who have developed pancreas problems from Victoza, including pancreatic cancer and acute pancreatitis. The Onder Law Firm's Victoza pancreatic cancer attorneys provide experienced legal representation without fee unless they collect for their clients.
We will represent all persons involved in Delaware Victoza pancreatic cancer or pancreatitis claims on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. Anyone who resides in Delaware and developed acute pancreatitis or pancreatic cancer from Victoza, or is a family member of such a person, is eligible to receive a free, no-obligation case review from our attorneys. Simply contact our firm through the online contact form or the chat feature and one of our Victoza pancreatic cancer lawyers will contact you promptly to discuss your case.
The Onder Law Firm is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation. For more information, visit www.OnderLaw.com or call 1-877-ONDER-LAW.